Targeted anticancer drugs block cancer cell growth by interfering with specific signaling
pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing …

Esophageal cancer (EC) is a common gastrointestinal malignancy with poor prognosis and
high mortality. Although combined therapeutic strategies have been developed, the 5-year …

Biomarker discovery and development are popular for detecting the subtle diseases.
However, biomarkers are needed to be validated and approved, and even fewer are ever …

Most hepatocellular carcinomas (HCCs) occur in cirrhotic livers, but unequivocal diagnosis
of early HCC from the fibrotic microenvironment remains a formidable challenge with …

Metallic nanoparticles (MNPs) have garnered significant attention due to their ability to
improve the therapeutic index of medications by reducing multidrug resistance and …

The pharmacological activity of organotin (IV) complexes in cancer therapy is well
recognized but their large applicability is hampered by their poor water solubility. Hence …

Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …

Metastasis accounts for greater than 90% of cancer-related deaths. Despite recent
advancements in conventional chemotherapy, immunotherapy, targeted therapy, and their …

Carbon quantum dots (CQDs) are gaining a lot more attention than traditional
semiconductor quantum dots owing to their intrinsic fluorescence property, chemical …

Protein nanocages have been studied extensively, due to their unique architecture,
exceptional biocompatibility and highly customization capabilities. In particular, ferritin …